Zydus Lifesciences' Q1 FY 2025-26 Quarterly Results
- 13 Aug 2025
Result Summary
- Zydus Lifesciences Ltd reported a 18.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 7.3%.
- Its expenses for the quarter were up by 16.0% QoQ and 10.0% YoY.
- The net profit increased 22.1% QoQ and increased 2.6% YoY.
- The earnings per share (EPS) of Zydus Lifesciences Ltd stood at 14.6 during Q1 FY 2025-26.
Financial Statments for Q1 FY 2025-26
| (₹ crores) | Q1FY26 | Q4FY25 | Q1FY25 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 6728.60 | 5690.20 | 6270.70 | 18.2% | 7.3% |
Total Expenses | 4808.00 | 4143.20 | 4371.00 | 16.0% | 10.0% |
Profit Before Tax | 1920.60 | 1547.00 | 1899.70 | 24.1% | 1.1% |
Tax | 434.00 | 321.20 | 436.10 | 35.1% | -0.5% |
Profit After Tax | 1521.00 | 1246.10 | 1482.50 | 22.1% | 2.6% |
Earnings Per Share | 14.60 | 11.70 | 14.10 | 24.8% | 3.5% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Zydus Lifesciences Ltd is a prominent company operating within the pharmaceutical industry, primarily engaged in the research, development, production, and marketing of a wide range of pharmaceutical products. This includes both generic and branded formulations, as well as active pharmaceutical ingredients (APIs). The company is known for its focus on therapeutic areas such as cardiology, gastroenterology, and diabetology, among others. Recent major developments in the company, if any, are not provided in the data.
Revenue
In the first quarter of FY26, Zydus Lifesciences Ltd reported a total income of ₹6728.60 crores. This marks a substantial quarter-over-quarter (QoQ) increase of 18.2% compared to ₹5690.20 crores in Q4FY25. Year-over-year (YoY), there is a growth of 7.3% when compared to the total income of ₹6270.70 crores in Q1FY25. This revenue growth is indicative of the company’s strong performance in generating sales and other income streams over the past year.
Profitability
For Q1FY26, Zydus Lifesciences Ltd achieved a Profit Before Tax of ₹1920.60 crores, which is a 24.1% increase from ₹1547.00 crores in Q4FY25 and a slight YoY increase of 1.1% from ₹1899.70 crores in Q1FY25. The Profit After Tax for Q1FY26 stands at ₹1521.00 crores, showing a QoQ rise of 22.1% from ₹1246.10 crores in Q4FY25 and a YoY growth of 2.6% from ₹1482.50 crores in Q1FY25. The company's Earnings Per Share (EPS) for Q1FY26 is ₹14.60, up by 24.8% QoQ from ₹11.70 and an increase of 3.5% YoY from ₹14.10.
Operating Metrics
Total expenses for Zydus Lifesciences Ltd in Q1FY26 were ₹4808.00 crores, reflecting a QoQ increase of 16.0% from ₹4143.20 crores in Q4FY25 and a YoY rise of 10.0% from ₹4371.00 crores in Q1FY25. Tax expenses for the same quarter amounted to ₹434.00 crores, which is a 35.1% increase QoQ from ₹321.20 crores in Q4FY25, while showing a slight YoY decline of 0.5% from ₹436.10 crores in Q1FY25. These figures highlight the company's operational scale and financial obligations over the respective periods.
FAQs
When was Zydus Lifesciences Ltd Q1 FY 2025-26 result announced?
Zydus Lifesciences Ltd announced its Q1 FY 2025-26 results on 13 August, 2025.
What are Zydus Lifesciences Ltd quarterly results?
Zydus Lifesciences Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
What were the key highlights of Zydus Lifesciences Ltd Q1 FY 2025-26 results?
Key highlights of Zydus Lifesciences Ltd Q1 FY 2025-26 results include:
- Revenue: ₹6728.60 crore
- Net Profit: ₹1521.00 crore
- EBITDA: ₹2243.40 crore
- Year-over-Year Growth: 7.3%
- Quarter-over-Quarter Growth: 18.2%
How did Zydus Lifesciences Ltd net profit perform in this quarter?
Zydus Lifesciences Ltd reported a net profit of ₹1521.00 crore in Q1 FY 2025-26, reflecting a 2.6% year-over-year growth.
What was Zydus Lifesciences Ltd revenue in Q1 FY 2025-26?
Zydus Lifesciences Ltd posted a revenue of ₹6728.60 crore in Q1 FY 2025-26.